Holen Sie sich die Stockscreener-App
5.12
0.39%
-0.02
Handel nachbörslich:
5.10
-0.02
-0.39%
Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten
Evoke Pharma sees FY25 net product sales of approx $16M - MSN
What machine learning models say about Evoke Pharma Inc.Market Trend Report & Fast Exit Strategy with Risk Control - Newser
Momentum divergence signals in Evoke Pharma Inc. chart2025 Earnings Impact & Free Technical Pattern Based Buy Signals - Newser
Evoke Pharma Inc. stock trendline breakdownJuly 2025 Fed Impact & AI Powered Market Entry Strategies - Newser
Visualizing Evoke Pharma Inc. stock with heatmapsEntry Point & Free Community Consensus Stock Picks - Newser
Can a trend reversal in Evoke Pharma Inc. lead to recoveryWeekly Volume Report & Safe Capital Growth Trade Ideas - Newser
Using RSI to spot recovery in Evoke Pharma Inc.July 2025 Decliners & Verified Momentum Stock Ideas - Newser
Evoke Pharma reports Q2 EPS (62c) vs (93c) last year - MSN
How sentiment analysis helps forecast Evoke Pharma Inc.Weekly Trade Analysis & Growth Oriented Trading Recommendations - Newser
Top Risks to Consider Before Buying Evoke Pharma Inc. StockTake Profit & Weekly Watchlist of Top Performers - Newser
Evoke Pharma Posts 47 Percent Q2 Growth - AOL.com
Short Interest in Evoke Pharma, Inc. (NASDAQ:EVOK) Decreases By 78.2% - Defense World
Evoke Pharma Reports Strong Q2 2025 Sales Growth - TipRanks
Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Evoke Pharma 2025 Q2 Earnings Mixed Performance with Net Loss Widening - AInvest
Elliott Wave Theory Predicts Pullback in Evoke Pharma Inc.2025 Breakouts & Breakdowns & Long-Term Growth Stock Strategies - newsyoung.net
Evoke Pharma Reports 47% Q2 Growth, Affirms FY Sales Outlook - AInvest
Evoke Pharma Q2 Earnings: Revenue at $3.75M, EPS of 62c - AInvest
RSI Reset May Fuel Rebound in Evoke Pharma Inc.Weekly Market Report & Smart Allocation Stock Reports - beatles.ru
Evoke Pharma, Inc. Confirms Sales Guidance for the Year 2025 - MarketScreener
Evoke Pharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Evoke Pharma Inc SEC 10-Q Report - TradingView
Gastroparesis Drug Maker Evoke Posts Strong Growth as GIMOTI Adoption Accelerates - Stock Titan
Backtesting results for Evoke Pharma Inc. trading strategiesEarnings Growth Summary & Free Verified High Yield Trade Plans - Newser
Is Evoke Pharma Inc. trending in predictive chart modelsJuly 2025 Short Interest & Weekly Return Optimization Alerts - Newser
Will Volume Confirm Reversal in Evoke Pharma Inc.July 2025 Market Mood & Fast Gain Stock Trading Tips - sundaytimes.kr
Using data filters to optimize entry into Evoke Pharma Inc.2025 Analyst Calls & Consistent Growth Equity Picks - Newser
Why Evoke Pharma Inc. stock attracts strong analyst attentionWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
Is Evoke Pharma Inc. a Top Dividend Stock to Watch in 2025Earnings Recap Summary & Consistent Return Investment Signals - Newser
Tools to monitor Evoke Pharma Inc. recovery probabilityIntelligent Trade Forecast With AI Analytics - Newser
Published on: 2025-08-11 01:03:10 - Newser
Evoke Pharma (EVOK) to Release Quarterly Earnings on Tuesday - Defense World
Will Evoke Pharma Inc. stock go up in YEARFastest Growing Stocks to Watch - thegnnews.com
Real time scanner hits for Evoke Pharma Inc. explainedHigh Probability Trade Outcome Prediction - Newser
2.80%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):